Multicenter Pediatric Low-Dose CT Protocol: Development and Clinical Verification

NCT ID: NCT07199101

Last Updated: 2025-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

2650 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-01

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children are sensitive to ionizing radiation, and there are significant regional variations in current pediatric CT radiation doses. Although there are studies on low-dose CT targeting single lesions, these studies require clear clinical indications and support from advanced equipment, making widespread promotion difficult. The establishment of low-dose CT protocols is mostly experience-based; when radiologists lack confidence in image quality, the credibility of diagnostic reports is compromised. Therefore, the development of low-dose protocols must meet the diagnostic confidence of most radiologists, enable clear visualization of key anatomical structures in clinical practice, and satisfy the requirements for disease diagnosis.

The purpose of this study is to establish a pediatric low-dose CT scanning protocol using Low-dose Simulation of CT (LDS) technology, and conduct a multicenter randomized controlled trial (RCT) in clinical settings to verify the clinical feasibility of this low-dose CT scanning protocol.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radiation Dose Reduction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

On the RCT trial procedure, Participants will be randomly assigned to the intervention group (adopting the pediatric low-dose CT protocol established based on LDS) or the conventional CT dose group (adopting China's pediatric CT Diagnostic Reference Level protocol) at a 1:1 ratio. A statistician who is not directly involved in the analysis of study results or image evaluation will develop independent randomization schemes for each participating center using the randomized block design, so as to further reduce inter-center bias and ensure the concealment of the allocation scheme.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine dose CT

Participants will undergo a routine dose CT adopting China's pediatric CT Diagnostic Reference Level protocol

Group Type NO_INTERVENTION

No interventions assigned to this group

Low dose CT

Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on LDS

Group Type EXPERIMENTAL

Low dose CT

Intervention Type RADIATION

Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on low dose simulation technique.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low dose CT

Participants will undergo a low dose CT adopting the pediatric low-dose CT protocol established based on low dose simulation technique.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 0-17 years.
* Pediatric patients for whom a CT examination is deemed necessary by an attending physician.

Exclusion Criteria

* Parents/guardians refuse to consent to low-dose CT examination.
* Pediatric patients are in critical condition, with no time allocated for explanation of the randomized controlled trial (RCT) protocol.
Minimum Eligible Age

0 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Children's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Children's Hospital, Capital Medical University, National Center for Children's Health

Beijing, Beijing Municipality, China

Site Status

Beijing Friendship Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status

Beijing Tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status

Medical Center for Capital Children's Health, Capital Medical University

Beijing, Beijing Municipality, China

Site Status

National Institute for Radiological Protection, China CDC

Beijing, Beijing Municipality, China

Site Status

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status

Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders.

Chongqing, Chongqing Municipality, China

Site Status

Guangdong Women and Children Hospital

Guangzhou, Guangdong, China

Site Status

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China

Site Status

Baoding Hospital, Beijing Children's Hospital Affiliated to Capital Medical University

Baoding, Heibei, China

Site Status

Fuwai Central China Cardiovascular Hospital

Zhengzhou, Henan, China

Site Status

The Third Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Site Status

Affiliated Women's Hospital of Jiangnan University

Wuxi, Jiangsu, China

Site Status

Children's Hospital of Changchun

Changchun, Jilin, China

Site Status

the First Hospital of Jilin University

Changchun, Jilin, China

Site Status

The First Affiliated Hospital of Xi'an Jiao Tong University

Xi'an, Shaanxi, China

Site Status

Shanghai Children's Medical Center, School of Medicine

Shanghai, Shanghai Municipality, China

Site Status

Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Site Status

ShanghaiTech University

Shanghai, Shanghai Municipality, China

Site Status

People's Hospital of Xinjiang Uygur Autonomous Region

Ürümqi, Xinjiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jihang Sun, MD

Role: CONTACT

+86 13521158011

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jihang Sun, MD

Role: primary

+86 13521158011

Yantao Niu, PhD

Role: primary

+86 13693664085

Dandan Liu, PhD

Role: primary

+86 13701124170

Wei Liu, MD

Role: primary

+86 13261960902

Ling He, MD

Role: primary

+86 13983399138

Zhiqiu Ye, MD

Role: primary

+86 13688898540

Ge Wen, MD

Role: primary

+86 13360022166

Lili Zang, MD

Role: primary

+86 15203220998

Yinghui Ge, MD

Role: primary

+86 13603989332

Xin Zhao, MD

Role: primary

+86 13676939116

Xinkai Zhao, MD

Role: primary

+86 15861600014

Jing Wang, MD

Role: primary

+86 15804300153

Jian Yang, MD

Role: primary

+86 18191975783

Yumin Zhong, MD

Role: primary

+86 18930830851

Dengbin Wang, MD

Role: primary

+86 13916656531

Yan Wang, MD

Role: primary

+86 13699982055

References

Explore related publications, articles, or registry entries linked to this study.

Xu H, Sun QF, Yue BR, Cheng JS, Niu YT. Results and analysis of examination doses for paediatric CT procedures based on a nationwide survey in China. Eur Radiol. 2024 Mar;34(3):1659-1666. doi: 10.1007/s00330-023-10005-7. Epub 2023 Sep 6.

Reference Type BACKGROUND
PMID: 37672054 (View on PubMed)

Bosch de Basea M, Thierry-Chef I, Harbron R, Hauptmann M, Byrnes G, Bernier MO, Le Cornet L, Dabin J, Ferro G, Istad TS, Jahnen A, Lee C, Maccia C, Malchair F, Olerud H, Simon SL, Figuerola J, Peiro A, Engels H, Johansen C, Blettner M, Kaijser M, Kjaerheim K, Berrington de Gonzalez A, Journy N, Meulepas JM, Moissonnier M, Nordenskjold A, Pokora R, Ronckers C, Schuz J, Kesminiene A, Cardis E. Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat Med. 2023 Dec;29(12):3111-3119. doi: 10.1038/s41591-023-02620-0. Epub 2023 Nov 9.

Reference Type BACKGROUND
PMID: 37946058 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

YGSKL-SHTech-2025-KF01

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2025-Y-131-D

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.